siRNA therapy reduces triglycerides in clients along with rare ailment

.INVESTIGATION FEATURE.19 September 2024.

Plozasiran minimized triglyceride amounts by 80% as well as reduced the threat of pancreatitis in individuals with constant chylomicronemia, along with or even without a hereditary diagnosis.